M. T. Cordero

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

Andrea L.A. Wong, Ross A. Soo, Daniel S.W. Tan et al. · Annals of Oncology · 2015 · 166 citations

Refractory Solid Malignancies, Medicine, Cancer Biology +8

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

Andrea Li Ann Wong, K. Y. Seng, Eugene Ong et al. · Breast Cancer Research and Treatment · 2014 · 77 citations

Obesity, Metabolic Syndrome, Breast Oncology +10

Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients

Yi Wan Lim, Brian C. Goh, L.-Z. Wang et al. · Annals of Oncology · 2010 · 24 citations · Full text

Medicine, Pharmacology, Ketoconazole Modulation +7

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

Daniel Chan, Wee-Lee Yeo, M. T. Cordero et al. · Investigational New Drugs · 2009 · 22 citations

Breast Oncology, Oncology, Medicine +8

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.

Andrea Li‐Ann Wong, Hui‐Ling Yap, Wee-Lee Yeo et al. · PubMed · 2012 · 18 citations